For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different life-threatening autoimmune diseases that had resisted years of treatment.
Sauna bathing releases white blood cells into the bloodstream, a new study from Finland shows. Circulating white blood cells play a key role in the body’s defense against various pathogens and diseases. The results were published in the journal Temperature.
“This study is the first to combine tissue nanotransfection (TNT) with nerve graft surgery, and the results are promising.
PITTSBURGH, April 8, 2026 /PRNewswire/ — “Our intention is to create a more accurate and exact wearable device to determine the onset of the female ovulation cycle and consequently when a female human or animal is most likely to become pregnant after insemination,” stated one of the two inventors, from Gainesville, Virginia, “hence the invention of the Ovulonics device. Our design would provide an easy, convenient and accurate detection time for human or animal
Researchers at the Institute of Biomedical Engineering at the University of Toronto have demonstrated a new way to monitor transplanted stem-cell-derived heart cells using magnetic resonance imaging (MRI).
Stem cell transplantation could be a rapid and effective way to restore hemoglobin production in individuals with the blood disorder β-thalassaemia.
A new single-cell technology is giving scientists their clearest view yet of immune cell behavior—capturing not just genetic intent, but real-time activity.
Carnegie Mellon researchers have proven that widely available earbuds can double as heart-monitoring devices, capturing subtle cardiac activity with near-clinical accuracy and potentially expanding access to long-term, at-home care.
Now, a research team led by Prof. Dr. Kai Wollert, Head of Molecular and Translational Cardiology at the Department of Cardiology and Angiology at Hannover Medical School (MHH), has discovered that a microprotein called BRICK1 plays a key role in this process.
A new study published in Cell from a team of investigators from the Stanford Departments of Urology and Radiation Oncology, in close collaboration with colleagues from Stanford Cancer Institute, offers a powerful new approach: using a non-invasive urine test to determine, at a molecular level, who benefits from additional therapy—and who does not.